E-LIB Suche - Ergebnisse für: Xia, Zhongjun

1

Ixazomib-based frontline therapy followed by ixazomib maint..:

Bao, Li ; Wang, Yu-Tong ; Liu, Peng...
eClinicalMedicine. 68 (2024) - p. 102431 , 2024

Link: https://doi.org/10.1016/..

2

Safety and feasibility analysis of rapid daratumumab infusi..:

Yin, Xi‐xi ; Hu, Yueyun ; Yang, Yusi...
Cancer Medicine. 13 (2024) 11 - p. , 2024

Link: https://doi.org/10.1002/..

3

Targeting P21-activated kinase suppresses proliferation and..:

Su, Ning ; Fang, Yu ; Chen, Xu...
Blood Science. 5 (2023) 4 - p. 249-257 , 2023

Link: https://doi.org/10.1097/..

4

P925: PHASE 1 TRIAL OF ANTI-CD38 MONOCLONAL ANTIBODY CM313 ..:

Chen, Wenming ; Huang, Zhongxia ; Fang, Baijun...
HemaSphere. 7 (2023) S3 - p. e1267740 , 2023

Link: https://doi.org/10.1097/..

5

Diagnostic performance and prognostic value of circulating ..:

Tian, Xiao-Peng ; Zhang, Yu-Chen ; Lin, Ning-Jing...
Cell Reports Medicine. 4 (2023) 2 - p. 100859 , 2023

Link: https://doi.org/10.1016/..

6

Orelabrutinib in relapsed or refractory chronic lymphocytic..:

Xu, Wei ; Zhou, Keshu ; Wang, Tingyu...
American Journal of Hematology. 98 (2023) 4 - p. 571-579 , 2023

Link: https://doi.org/10.1002/..

7

Global miRNA profiling reveals key molecules that contribut..:

Liu, Panpan ; Wang, Kefeng ; Li, Jianan...
Haematologica. 109 (2023) 2 - p. 479-492 , 2023

Link: https://doi.org/10.3324/..

8

P949: COMBINATION GA AND MPR VULNERABILITY SCORING TOOLS EF..:

Lu, Minqiu ; Peng, Liu ; Zhuang, Junling...
HemaSphere. 7 (2023) S3 - p. e46772d6 , 2023

Link: https://doi.org/10.1097/..

9

Aponermin or placebo in combination with thalidomide and de..:

Xia, Zhongjun ; Leng, Yun ; Fang, Baijun...
BMC Cancer. 23 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

10

Malignant clonal evolution drives multiple myeloma cellular..:

Liang, Yuanzheng ; He, Haiyan ; Wang, Weida...
Molecular Cancer. 21 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

11

Development of a Risk Assessment Model for Early Grade ≥ 3 ..:

Shang, Yufeng ; Wang, Weida ; Liang, Yuxing...
Frontiers in Oncology. 12 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

12

Efficacy and safety comparison between R-CHOP and modified ..:

Guan, Jinqiu ; Sun, Feifei ; Wang, Juan...
Annals of Hematology. 101 (2022) 4 - p. 763-771 , 2022

Link: https://doi.org/10.1007/..

13

Ibrutinib as monotherapy versus combination therapy in Chin..:

Zhang, Yuchen ; Liu, Panpan ; Cai, Jun...
Cancer Medicine. 11 (2022) 22 - p. 4134-4145 , 2022

Link: https://doi.org/10.1002/..

14

Selinexor plus low-dose dexamethasone in Chinese patients w..:

Qiu, Lugui ; Xia, Zhongjun ; Fu, Chengcheng...
BMC Medicine. 20 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

15

3D Quality Evaluation of Rock Mass in Urban Underground Spa..:

Peng, Zhisong ; Su, Peidong ; Chen, Wuyi...
KSCE Journal of Civil Engineering. 26 (2022) 11 - p. 4829-4839 , 2022

Link: https://doi.org/10.1007/..